It’s competition time! You might have noticed that we have a shiny new F1000 homepage. We’re hoping that this new look will make it more clear what we do to the casual browser, without losing the functionality you’ve all come to know, love and expect.
When you first fall in love, the passion can be intense, even burning. The object of affection is perfect in every way, they can do no wrong. After a while, that feeling begins to wear off. Maintaining interest and passion becomes hard work. It’s easier to criticize than to be complimentary.
Twitter, what is it good for? Yesterday evening, a good fifty or so scientists, clinicians, students, journal editors and other interested parties took part in a twitter journal club–as far as I know, the first of its kind. The Twitter Journal Club, or #TwitJC, is the brainchild of Fi Douglas and Natalie Silvey; a Cambridge…
Last Wednesday I found myself at the Prince Charles Theatre, Leicester Square, for the premiere of rapper Baba Brinkman’s new project, the teaching version of The Rap Guide to Evolution. I had been looking forward to this, having come across Brinkman at a rather dodgy bar in North London last year.
Following on from my post yesterday about the ongoing UK House of Commons Select Committee on Science and Technology peer review enquiry, the oral session that Faculty of 1000 (F1000) took part in focussed on a long and interesting discussion about splitting up the review process into two constituent parts as the Public Library of…
Imagine there was a disease, with often devastating consequences, the causative agent of which remains elusive. Then, a paper is published identifying such a potential virus, causing great rejoicing especially among patient advocacy groups, who have struggled to convince medics that the disease is a real one–that is, not only psychosomatic. They have hope now…
The UK House of Commons Select Committee on Science and Technology launched an enquiry on peer review earlier this year, and invited Faculty of 1000 (F1000) to take part. The real rationale for holding this enquiry is still somewhat of a mystery to many of us who were invited to present but it appears to…
We’d like to extend our congratulations to the F1000 Members who are in the 2011 class of the American Academy of Arts and Sciences: Section Heads Katherine High – Hematology Talmadge Everett King Jr – Respiratory Disorders Peter Reich – Ecology Kevan Shokat – Chemical Biology Marvin Wickens – Cell Biology Faculty Members Robert Colwell…
Guest post from Dr Nigel Eastmond, a medical writer. I come to you today from the Dark Side of the Force. My Star Destroyer is parked outside and it runs on a potent mix of misery and death, but at least it’s paid for. Excuse me while I remove my Stormtrooper helmet and introduce myself…
You may have seen the kerfuffle over Facebook and pharma companies that’s just blown up. In brief, pharmaceutical companies used to be able to whitelist comments on their Facebook pages, mainly because of regulatory concerns and uncertainty over the FDA’s position on social media. It’s not just pharma–managers of disease awareness pages and what-have-you could…
